Literature DB >> 27377644

Luteolin reduces obesity-associated insulin resistance in mice by activating AMPKα1 signalling in adipose tissue macrophages.

Lei Zhang1, Yi-Jing Han1, Xian Zhang1, Xin Wang1, Bin Bao1, Wei Qu1, Jian Liu2.   

Abstract

AIMS/HYPOTHESIS: Inflammatory polarisation of adipose tissue macrophages (ATMs) plays a critical role in the development of obesity-associated metabolic diseases such as insulin resistance and diabetes. Our previous study indicated that dietary luteolin (LU) could prevent the establishment of insulin resistance in mice fed a high-fat diet (HFD). Here, we further investigated the effects of LU, which is a natural flavonoid, on pre-established insulin resistance and obesity-associated ATM polarisation in mice.
METHODS: Five-week-old C57/BL6 mice were fed on a low-fat diet or HFD for 20 weeks, with some mice receiving supplementation with 0.01% LU from weeks 1 or 10 of the HFD to assess the actions of LU on insulin resistance and ATM polarisation. Furthermore, the role of LU in metabolic-dysfunction-associated macrophage phenotypes was investigated in vitro.
RESULTS: Dietary LU supplementation, either for 20 weeks or from weeks 10 to 20 of an HFD, significantly improved insulin resistance in HFD-fed mice. In addition, inflammatory macrophage infiltration and polarisation were suppressed in mouse epididymal adipose tissues. Furthermore, LU treatment directly reversed lipopolysaccharide-stimulated and metabolism-regulated molecules, and induced inflammatory polarisation in mouse RAW264.7 cells and peritoneal cavity resident macrophages. Finally, using the selective AMP-activated protein kinase (AMPK) inhibitor compound C and Ampkα1 (also known as Prkaa1) silencing with siRNA, we found that LU activated AMPKα1 in macrophages to inhibit their inflammatory polarisation and enhanced insulin signals in adipocytes that were stimulated with macrophage-conditioned media. CONCLUSIONS/
INTERPRETATION: Dietary LU ameliorated insulin resistance in diet-induced obese mice by promoting AMPKα1 signalling in ATMs.

Entities:  

Keywords:  AMPKα1; Adipose tissue macrophage; Insulin resistance; Luteolin; Polarisation

Mesh:

Substances:

Year:  2016        PMID: 27377644     DOI: 10.1007/s00125-016-4039-8

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  38 in total

1.  Reduction of lipid accumulation in HepG2 cells by luteolin is associated with activation of AMPK and mitigation of oxidative stress.

Authors:  Jin-Feng Liu; Ying Ma; Ying Wang; Zhi-Yan Du; Jing-Kang Shen; Hong-Li Peng
Journal:  Phytother Res       Date:  2010-10-05       Impact factor: 5.878

Review 2.  AMPK promotes macrophage fatty acid oxidative metabolism to mitigate inflammation: implications for diabetes and cardiovascular disease.

Authors:  Gregory R Steinberg; Jonathan D Schertzer
Journal:  Immunol Cell Biol       Date:  2014-03-18       Impact factor: 5.126

Review 3.  Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases.

Authors:  Jia-Ming Xu; Guo-Ping Shi
Journal:  Endocr Rev       Date:  2012-01-12       Impact factor: 19.871

Review 4.  Type 2 diabetes as an inflammatory disease.

Authors:  Marc Y Donath; Steven E Shoelson
Journal:  Nat Rev Immunol       Date:  2011-01-14       Impact factor: 53.106

Review 5.  Adipokines in inflammation and metabolic disease.

Authors:  Noriyuki Ouchi; Jennifer L Parker; Jesse J Lugus; Kenneth Walsh
Journal:  Nat Rev Immunol       Date:  2011-01-21       Impact factor: 53.106

Review 6.  Abdominal obesity and metabolic syndrome.

Authors:  Jean-Pierre Després; Isabelle Lemieux
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

7.  Quercetin, luteolin, and epigallocatechin gallate promote glucose disposal in adipocytes with regulation of AMP-activated kinase and/or sirtuin 1 activity.

Authors:  Na Xiao; Fan Mei; Yan Sun; Guojun Pan; Baolin Liu; Kang Liu
Journal:  Planta Med       Date:  2014-07-24       Impact factor: 3.352

Review 8.  The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance.

Authors:  Jindrich Chmelar; Kyoung-Jin Chung; Triantafyllos Chavakis
Journal:  Thromb Haemost       Date:  2013-01-31       Impact factor: 5.249

9.  Low-dose diet supplement of a natural flavonoid, luteolin, ameliorates diet-induced obesity and insulin resistance in mice.

Authors:  Na Xu; Lei Zhang; Jing Dong; Xian Zhang; Yan-Guang Chen; Bin Bao; Jian Liu
Journal:  Mol Nutr Food Res       Date:  2014-02-24       Impact factor: 5.914

10.  Luteolin inhibits inflammatory responses via p38/MK2/TTP-mediated mRNA stability.

Authors:  Wanling Wu; Dongye Li; Yu Zong; Hong Zhu; Defeng Pan; Tongda Xu; Tao Wang; Tingting Wang
Journal:  Molecules       Date:  2013-07-09       Impact factor: 4.411

View more
  12 in total

1.  A long-term anti-inflammation markedly alleviated high-fat diet-induced obesity by repeated administrations of overexpressing IL10 human umbilical cord-derived mesenchymal stromal cells.

Authors:  Liudi Wang; Tianyun Gao; Yu Li; Yuanyuan Xie; Sheng Zeng; Chenxu Tai; Yirui Feng; Pingping Shen; Bin Wang
Journal:  Stem Cell Res Ther       Date:  2022-06-17       Impact factor: 8.079

2.  Luteolin decreases atherosclerosis in LDL receptor-deficient mice via a mechanism including decreasing AMPK-SIRT1 signaling in macrophages.

Authors:  Jiang Li; Jian-Zeng Dong; Yan-Long Ren; Jia-Jia Zhu; Jia-Ning Cao; Jing Zhang; Li-Li Pan
Journal:  Exp Ther Med       Date:  2018-07-20       Impact factor: 2.447

3.  A novel biosensor based on intestinal 3D organoids for detecting the function of BCRP.

Authors:  Lei Zhang; Junfang Zhao; Chenmeizi Liang; Mingyao Liu; Feng Xu; Xin Wang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

4.  High glucose suppresses the viability and proliferation of HTR‑8/SVneo cells through regulation of the miR‑137/PRKAA1/IL‑6 axis.

Authors:  Hai-Yan Peng; Ming-Qing Li; Hua-Ping Li
Journal:  Int J Mol Med       Date:  2018-05-17       Impact factor: 4.101

Review 5.  The Targeted Impact of Flavones on Obesity-Induced Inflammation and the Potential Synergistic Role in Cancer and the Gut Microbiota.

Authors:  Meenakshi Sudhakaran; Andrea I Doseff
Journal:  Molecules       Date:  2020-05-27       Impact factor: 4.411

6.  Luteolin-Enriched Artichoke Leaf Extract Alleviates the Metabolic Syndrome in Mice with High-Fat Diet-Induced Obesity.

Authors:  Eun-Young Kwon; So Young Kim; Myung-Sook Choi
Journal:  Nutrients       Date:  2018-07-27       Impact factor: 5.717

7.  Decrease of AIM2 mediated by luteolin contributes to non-small cell lung cancer treatment.

Authors:  Qian Yu; Minda Zhang; Qidi Ying; Xin Xie; Shuwen Yue; Bending Tong; Qing Wei; Zhaoshi Bai; Lingman Ma
Journal:  Cell Death Dis       Date:  2019-03-04       Impact factor: 8.469

Review 8.  Paving Luteolin Therapeutic Potentialities and Agro-Food-Pharma Applications: Emphasis on In Vivo Pharmacological Effects and Bioavailability Traits.

Authors:  Yasaman Taheri; Javad Sharifi-Rad; Gizem Antika; Yakup Berkay Yılmaz; Tugba Boyunegmez Tumer; Sawsan Abuhamdah; Subhash Chandra; Sarla Saklani; Ceyda Sibel Kılıç; Simona Sestito; Sevgi Durna Daştan; Manoj Kumar; Mohammed M Alshehri; Simona Rapposelli; Natália Cruz-Martins; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2021-09-20       Impact factor: 6.543

9.  Broussonetia papyrifera Root Bark Extract Exhibits Anti-inflammatory Effects on Adipose Tissue and Improves Insulin Sensitivity Potentially Via AMPK Activation.

Authors:  Jae Min Lee; Sun Sil Choi; Mi Hyeon Park; Hyunduk Jang; Yo Han Lee; Keon Woo Khim; Sei Ryang Oh; Jiyoung Park; Hyung Won Ryu; Jang Hyun Choi
Journal:  Nutrients       Date:  2020-03-14       Impact factor: 5.717

10.  Feeding brown fat: dietary phytochemicals targeting non-shivering thermogenesis to control body weight.

Authors:  Carla Horvath; Christian Wolfrum
Journal:  Proc Nutr Soc       Date:  2020-04-15       Impact factor: 6.297

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.